biostudies-literatureUnknown3(2)Silang K<h4>Background</h4>Preeclampsia affects between 2% and 5% of pregnant people in North America. First-trimester preeclampsia screening based on the Fetal Medicine Foundation risk calculation algorithm combined with treatment of high-risk patients with aspirin effectively reduces the incidence of preterm preeclampsia more than the currently used risk factor-based screening. However, the impact of such screening on patient satisfaction and maternal anxiety is unknown.<h4>Objective</h4>This study aimed to assess the impact of first-trimester prediction and prevention of preterm preeclampsia on patient satisfaction and anxiety.<h4>Study design</h4>Consenting pregnant patients participating in a local first-trimester (11-13+6 weeks) preterm preeclampsia screening and prevention implementation stAJOG global reports100205https://www.ebi.ac.uk/biostudies/studies/S-EPMC10165256biostudies-literatureFirst-trimester preeclampsia screening and prevention: impact on patient satisfaction and anxiety.PMC10165256Silang KPastuck MJohnson JAMaxey CTomfohr-Madsen LfalseFirst-trimester preeclampsia screening and prevention: impact on patient satisfaction and anxiety.<h4>Background</h4>Preeclampsia affects between 2% and 5% of pregnant people in North America. First-trimester preeclampsia screening based on the Fetal Medicine Foundation risk calculation algorithm combined with treatment of high-risk patients with aspirin effectively reduces the incidence of preterm preeclampsia more than the currently used risk factor-based screening. However, the impact of such screening on patient satisfaction and maternal anxiety is unknown.<h4>Objective</h4>This study aimed to assess the impact of first-trimester prediction and prevention of preterm preeclampsia on patient satisfaction and anxiety.<h4>Study design</h4>Consenting pregnant patients participating in a local first-trimester (11-13+6 weeks) preterm preeclampsia screening and prevention implementation st2023-01-01T00:00:00Z2023 May2025-04-18T15:13:16.58Z2025-04-07T01:47:28.485ZS-EPMC101652563716854510.1016/j.xagr.2023.100205